Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) have received an average recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average twelve-month price […]
More Stories
Outset Medical (OM) Set to Announce Quarterly Earnings on Wednesday
Outset Medical (NASDAQ:OM – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on...
SPDR Bloomberg Convertible Securities ETF (NYSEARCA:CWB) Sets New 1-Year High – What’s Next?
SPDR Bloomberg Convertible Securities ETF (NYSEARCA:CWB – Get Free Report)’s stock price hit a new 52-week high on Monday ....
Alliance Resource Partners, L.P. (NASDAQ:ARLP) Plans Quarterly Dividend of $0.70
Alliance Resource Partners, L.P. (NASDAQ:ARLP – Get Free Report) announced a quarterly dividend on Monday, October 28th, RTT News reports....
Brown & Brown (NYSE:BRO) Announces Earnings Results
Brown & Brown (NYSE:BRO – Get Free Report) released its earnings results on Monday. The financial services provider reported $0.91...
PureCycle Technologies (NASDAQ:PCT) Shares Down 2.8% – Time to Sell?
PureCycle Technologies, Inc. (NASDAQ:PCT – Get Free Report) was down 2.8% on Monday . The stock traded as low as...
Spectral AI (MDAI) Set to Announce Earnings on Wednesday
Spectral AI (NASDAQ:MDAI – Get Free Report) will post its quarterly earnings results after the market closes on Wednesday, November...